MedPath

Greater Occipital Nerve Pulsed Radiofrequency for the Treatment of Combined Migraine and Cervicogenic Headache (New Approach)

Not Applicable
Completed
Conditions
Greater Occipital Nerve
Pulsed Radiofrequency
Interventions
Procedure: proximal ultrasound-guided GON radiofrequency ablation
Procedure: distal ultrasound-guided GON radiofrequency ablation
Registration Number
NCT06121037
Lead Sponsor
Assiut University
Brief Summary

Combined migraine and cervicogenic headache present significant challenges in clinical management due to their complex and overlapping pathophysiologies. Both conditions involve the trigeminocervical complex, suggesting a potential shared anatomical and neurobiological basis

Detailed Description

Traditional treatment approaches for these headaches often include pharmacological interventions, but in cases of refractory or inadequate response, interventional techniques targeting the greater occipital nerve (GON) have gained attention.

Radiofrequency ablation (RFA) has gained recognition as a potential therapeutic option for patients with refractory combined migraine and cervicogenic headaches. The proximal and distal ultrasound-guided approaches are widely utilized for GON RFA. These approaches aim to disrupt pain signals transmitted by the GON and provide relief of pain for these headache disorders

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
60
Inclusion Criteria
  • Patients diagnosed with combined migraine and cervicogenic headache according to The International Classification of Headache Disorders (ICHD)
  • Age between 18 and 65 years.
  • Willingness to participate and provide informed consent
Exclusion Criteria
  • Previous neurosurgical procedures for headache management.
  • Patients with contraindications for the RF technique
  • Pregnancy or lactation
  • History of psychiatric disorders or substance abuse

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Proximal groupproximal ultrasound-guided GON radiofrequency ablationproximal ultrasound-guided GON radiofrequency ablation
Distal groupdistal ultrasound-guided GON radiofrequency ablationdistal ultrasound-guided GON radiofrequency ablation
Primary Outcome Measures
NameTimeMethod
Numerical rating scorebaseline and at follow-up visits (2 weeks.1, 2.3, and 6 months)

0-10 scale, with 0 indicating no pain and 10 indicating the worst possible pain.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Assiut governorate

🇪🇬

Assiut, Egypt

© Copyright 2025. All Rights Reserved by MedPath